25.11.2022 CompuGroup Medical SE & Co. KGaA  DE000A288904

EQS-News: ​​​​​​​CompuGroup Medical plans cooperation with SAP in the hospital sector


 

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Alliance
​​​​​​​CompuGroup Medical plans cooperation with SAP in the hospital sector

25.11.2022 / 10:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


Koblenz. CompuGroup Medical (CGM), one of the world’s leading e-health providers, plans a future cooperation with SAP, one of the world's leading providers of software for managing business processes, in the hospital sector. By combining the expertise of both companies, new intelligent solutions are to be created that are specifically tailored to the requirements of the inpatient sector, in order to support the hybrid modular system landscapes of our customers in the best possible and future-proof manner.

SAP and CGM have signed a letter of intent regarding a planned cooperation in the areas of solution integration and go-to-market today, against the background of SAP's decision to offer a standardized platform based on the Fast Health Interoperability (FHIR) standard for connecting hospital information systems.

As part of the planned collaboration and in addition to CGM CLINICAL, CGM will also develop the Revenue Cycle Management (RCM) to cover all administrative and clinical processes in hospitals in the future. RCM refers to the billing and financial process used by hospitals to track the different phases of patient care. SAP will contribute its expertise to the development of this new solution.

Together, the partners will ensure deep process integration of the RCM into the SAP ERP world (e.g. Finance, Accounting, HR) based on the FHIR standard. Both, a cloud and on-premise solution will be offered.

"I am very much looking forward to the collaboration with SAP - after all, two leading German software companies are finally coming together to powerfully advance the digitization so urgently needed in the healthcare sector with innovative solutions. With this partnership, we will offer a long-term end-to-end solution for our customers, both from a technological and process perspective" comments Hannes Reichl, Managing Director Inpatient and Social Care at CGM, on the planned collaboration.

"It needs strong partners with domain know-how along the value chain to develop added values for a digital transformation. With CGM, we have found an experienced partner in healthcare. Complemented by CGM's products, we can offer comprehensive healthcare solutions that are technologically leading while supporting clinical, administrative, and financial processes. This enables us to offer our customers long-term continuity and added value at the same time." Jan Gilg, President and Chief Product Officer SAP S/4 Hana, elaborates.

 

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.025 billion in 2021, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 8,500 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

 



25.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1497431

 
End of News EQS News Service

1497431  25.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1497431&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 582,38 717,02 745,81 837,26 1.025,32 1.129,74 1.187,66
EBITDA1,2 128,44 187,84 178,13 197,48 213,39 216,35 229,76
EBITDA-Marge3 22,05 26,20 23,88 23,59 20,81 19,15
EBIT1,4 90,07 143,23 115,27 121,77 102,68 104,03 113,96
EBIT-Marge5 15,47 19,98 15,46 14,54 10,01 9,21 9,60
Jahresüberschuss1 31,74 96,34 66,15 73,42 69,03 74,12 46,87
Netto-Marge6 5,45 13,44 8,87 8,77 6,73 6,56 3,95
Cashflow1,7 85,82 136,35 110,50 149,93 165,27 145,03 179,53
Ergebnis je Aktie8 0,63 1,92 1,33 1,40 1,30 1,40 0,88
Dividende8 0,35 0,50 0,50 0,50 0,50 0,50 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 27,860 Halten 1.497,05
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
21,43 35,69 0,62 23,91
KBV KCV KUV EV/EBITDA
2,43 8,34 1,26 9,47
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 1,00 3,59 22.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-8,26% -23,40% -26,49% -44,01%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei EQS abrufen


Software , A28890 , COP , XETR:COP